Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

H3F3A mutation as a marker of malignant giant cell tumor of the bone: A case report and review of literature.

Journal of cancer research and therapeutics - 1 Jan 2000

Ratnagiri Ranganath, Uppin Shantveer

Abstract excerpt

Giant cell tumor of the bone (GCTB) is a locally aggressive lesion, which characteristically arises from the epimetaphyseal region of long bones. They occur commonly in the third or fourth decade of life with a slight female preponderance. Various lesions such as chondroblastoma, aneurysmal bone cysts, and nonossifying fibromas can mimic the radiologic appearance of giant cell tumors. However, the greatest...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Neoplasms
Share to Histones
Share to Immunohistochemistry

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Source

Identifiers

PMID: 37470622
DOI: 10.4103/jcrt.jcrt_247_21

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

H3F3A mutation as a marker of malignant giant cell tumor of the bone: A case report and review of literature.PMID 37470622Read ↗

H3-3A gene mutation analysis in giant cell tumor of bone and its histologic mimics: A single institutional study from India.Semantic proximity Read ↗

Histone H3.3 mutation in giant cell tumor of bone: an update in pathology.Semantic proximity Read ↗

Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India.Semantic proximity Read ↗

H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors.Semantic proximity Read ↗

Reliability and Role of Mutation-specific H3F3A (Histone 3-3) G34W Immunohistochemistry to Differentiate Giant Cell Tumor of Bone From its Clinicoradiologic and Histologic Mimics: An Institutional Study.Semantic proximity Read ↗

H3.3G34W immunohistochemistry negative giant cell tumour of bone. Extended analysis of 35 such cases from a single institution in India.Semantic proximity Read ↗

H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone.Semantic proximity Read ↗

H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases.Semantic proximity Read ↗

Giant cell tumor of bone with H3F3B mutation: A case report.Semantic proximity Read ↗

Histologic Spectrum of Giant Cell Tumor (GCT) of Bone in Patients 18 Years of Age and Below: A Study of 63 Patients.Semantic proximity Read ↗

Osteosarcomas with H3F3A mutation a clinicopathological and molecular genetic study of 7 cases with review of the literature.Semantic proximity Read ↗

Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.